Tobramycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 39822-0412

7 FDA label images from Xgen Pharmaceuticals Djb, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 39822-0412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Tobramycin For Injection Usp 2)

Image (Tobramycin For Injection Usp 2)
Chemical structure of the active ingredient Tobramycin, shown as a molecular diagram with multiple amino and hydroxyl groups in a complex ring system.*
FDA Label Image

Reduced Dosage Nomogram Creatine Clearance (Tobramycin For Injection Usp 4)

Reduced Dosage Nomogram Creatine Clearance (Tobramycin For Injection Usp 4)
A reduced dosage nomogram chart showing the relationship between serum creatinine levels (mg/100 mL) on the x-axis and percent of normal dosage from Table 1 on the y-axis. It includes creatinine clearance adjusted for body surface area (mL/min/1.73 m²) along the top axis to assist in dosage calculations.*
FDA Label Image

Rx Only (Tobramycin For Injection Usp 5)

Rx Only (Tobramycin For Injection Usp 5)
Tobramycin 1.2 g/30mL injection, powder, lyophilized, for solution, intravenous use. The label contains details including the proprietary and generic names, route, and manufacturer XGen Pharmaceuticals DJB, Inc. The packaging primarily uses white and purple colors with the label text in black.*
FDA Label Image

Logo (Tobramycin For Injection Usp 6)

FDA Label Image

Tobra-mv-label (Tobramycin Label30aug2025 Plc591)

Tobra-mv-label (Tobramycin Label30aug2025 Plc591)
Tobramycin for Injection, USP 1.2 grams per vial lyophilized powder for solution injection by intravenous use. The label indicates it is a pharmacy bulk package not for direct infusion, manufactured by XGen Pharmaceuticals DJB, Inc., with additional instructions on preparation, storage, and usage. The vial is labeled with NDC 39822-0412-1 and states it is made in India.*
FDA Label Image

Tobra-mv-single-carton (Tobramycin For Injection 1.2gm 50ml Single Carton)

Tobra-mv-single-carton (Tobramycin For Injection 1.2gm 50ml Single Carton)
Packaging label for Tobramycin Injection, USP 1.2 gm per vial by XGen Pharmaceuticals DJB, Inc. This pharmacy bulk package is a lyophilized powder for intravenous injection, intended for preparing IV admixtures only, containing one vial per package with NDC 39822-0412-1. The label includes preparation instructions, storage conditions, and disclaimer that it is not for direct infusion.*
FDA Label Image

Tobra-mv-multi-carton (Tobramycin For Injection1.2gm 50ml Multi Carton)

Tobra-mv-multi-carton (Tobramycin For Injection1.2gm 50ml Multi Carton)
Packaging label for Tobramycin for Injection, USP, 1.2 gm per vial, injection powder for intravenous use by XGen Pharmaceuticals DJB, Inc. The label states this is a pharmacy bulk package with 6 vials of 1.2 grams each and highlights storage and preparation instructions, including reconstitution and usage timeframes. The product NDC is 39822-0412-6.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.